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Host-Guest complexation of octakis(diphenoxyphosphoryloxy)tetramethylcalix[4]resorcinarene 
CRA and 5,17-bis-(N-tolyliminomethyl)-25,27-dipropoxycalix[4]arene CA with  bio relevant 
aromatic, pyridine and diterpenoid carboxylic acids in water-organic solution had been studied by 
the RP HPLC and molecular modelling methods. The stability constants KA (387-1914 М-1) of the 
supramolecular complexes had been determined. It was shown the Host-Guest interactions are 
depended on structure of the Host molecules and  log P  values of the Guests. The complexation is 
determined by the hydrogen bonds of the COOH group of the carboxylic acids with P=O oxygen 
atom of diphenoxyphosphoryl group of the calixresorcinarene CRA, and oxygen or nitrogen atoms 
located on the lower or the upper rim of the calixarene CA.  
________________________________________________________________________________ 
Introduction 
Molecular recognition, membrane transport 
and analytical sensing of bio relevant carboxylic 
acids [1,2,3,4] by artificial receptors constitute 
an important problem in chemistry and biology 
[5,6]. The receptor properties of functionalized 
calixarenes toward the bio relevant molecules 
[7] make them highly promising materials for 
sensor technologies [8], as well as Host 
molecules for drug delivery systems in 
pharmaceutical science [9,10]. 
Calixarenes [11] contained preorganized bio-
affine groups are able to recognize different bio 
relevant molecules such as aromatic acids, 
dipeptides, proteins, choline and acetylcholine, 
carbohydrates, nucleotides, nucleosides and  
other organic substances [12,13,14,15]. 
Calixarene derivatives can also be fastened on 
the surface of proteins [16,17]. Calixarenes also 
simulate substrate-receptor interactions in  bio-
chemical processes [18,19]. 
Formerly it was shown that 
calix[4]arenes functionalized by appopriate 
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functional groups are effective receptors for 
aromatic compounds  [20,21,22]. The receptor 
activity is essentially depended from the number 
of the functional groups, geometrical parameters 
and stereochemical configuration of the 
macrocyclic platform as well.  
 
 
 
 
       CRA                                            CA 
 
 
 
 
 
 
 
 
 
Sсheme. The CRA and CA (Hosts) and 
p-coumaric 1, cinnamic 2, caffeic 3, gallic 4, 
diphenylacetic 5, picolinic 6, quinolinic 7, 
dipicolinic 8, izocinchomeronic 9, quinaldinic 
10, pimaric 11, maleopimaric 12 , palustric 13, 
dehydroabietic 14, abietic 15 and neoabietic 16 
acids (Guests). 
The aim of this work was to study the 
Host-Guest complexation  of the 
octakis(diphenoxyphosphoryloxy)tetramethyl-
calix[4]resorcinarene CRA and 5,17-bis-(N-
tolyliminomethyl)-25,27-dipropoxycalix[4]-
arene CA with the aromatic, pyridine and 
diterpenoid carboxylic acids 1-16 (Scheme). 
Reversible-phase high-performance 
liquid chromatography method (RP HPLC) was 
used for determination of the stability constants 
of the supramolecular complexes formed.  
Results and discussion 
Usually, for the determination of the 
stability constants of the cаlіxаrеne Host-Guest 
complexes with organic molecules the NMR, 
calorimetry, UV, fluorescent spectroscopy 
methods are widely used [9,23,24,25,26]. 
However in some cases due to poor solubility of 
the cаlіxаrеnes or the Guest molecules оr the 
absence of a corresponding instrumental 
response on the complexation process the above 
menthioned methods are inefficient. To solve 
this problem we have developed RP HPLC 
method for the determination stability constants 
of the calixarene complexes with organic 
compounds in water or water-organic solutions 
[27,28,29,30]. The method includes the 
determination of retention factor k' of the Guest 
molecule before and after calixarene addition to 
the mobile phase. The stability constant KA of 
the calixarene complex with the Guest molecule 
(for 1:1 stoichiometry) can be calculated by 
equation (1) [20]:                                       
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1/k’ = 1/k0’ + KA [CA]/k0’ (1), 
whеre k0’ and k’ are retention factors of the 
Guest molecule determined in the absence and 
in the presence of the cаlіxаrеne in the mobile 
phase.   
The calixarenes and the acids were 
registered on the chromatograms by the sharp 
peaks. Linear adsorption isotherm (r=0.99) 
indicated on its reversible sorption on the solid 
support surface (LiChrosorb RP 18).  
An addition of the CA or CRA to the 
mobile phase decreases the retention factor k’ of 
the acids. The linear character plots of k’ s the 
CA and CRA concentration testifies the 
formation of the Host-Guest inclusion 
complexes with 1:1 stoichiometry and allows 
the correct calculation КА values by the equation 
(1). 
The stability constants KA and free Gibbs 
energy G (G = -RT lnKA) for CA and CRA 
complexes with the acids are presented in Table 
1. 
 
 
 
 
 
 
 
 
Table 1. Stability constants KA (M 
-1) and free 
Gibbs energy G (kJ/моl) of the complexes  
№ Аcid 
CRA   CA  
КА  G КА  G 
Aromatic acids  
1 p-Coumaric  692 -16,18 - - 
2 Cinnamic 941  -16.94 - - 
3 Caffeic 520  -15.47 - - 
4 Gallic 625 -15.92 - - 
5 Diphenyl acetic  387  -14.74 - - 
Pyridine acids  
6 Picolinic 770 -16.44 - - 
7 Quinolinic 1914 -18.69 - - 
8 Dipicolinic 1572 -18.20 - - 
9 Isocinchomeronic 1895 -18.67 - - 
10 Quinaldinic 584 -15.76 - - 
Diterpenoid acids 
11 Pimaric  395 -14.79 1268 -17.67 
12 Maleopimaric  548 -15.60 1102 -17.33 
13 Palustric  464 -15.19 1121 -17.37 
14 Dehydroabietic  640 -15.98 1158 -17.45 
15 Abietic  557 -15.64 862 -16.72 
16 Neoabietic  682 -16.14 844 -16.70 
*relative standard deviation (RSD) is 5-24 % 
  The stability constants are depended on 
structure of Host and Guest molecules and vary 
from 387 M-1 (complex CA with diphenylacetic 
acid 5) tо 1914 M-1  (complex CA with 
quinolinic acid 7) (Table 1).  
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   Hydrophobic interactions between the 
Host and Guest molecules influence the 
complex stability in the water-organic solutions. 
This is clear to see from the dependence of KA 
values of the CRA and CA complexes from log 
P of the diterpenoid acids 11-16 [31] (Figures 
1,2). 
 
Figure 1. Plots of log P of diterpenoid 
acids 11-16 on their КА complexes with CRA.  
 
Figure 2. Plots of log P of diterpenoid 
acids 11-16 on their КА complexes with CA.  
As is shown in Figure 1 KA values for  
CRA complexes increase with increasing of the 
log P diterpenoid acids. At the same time 
increasing of the  log P  decreases KA values for  
the CA complexes (Figure 2).  
To clarify the nature of the Host-Guest 
interaction the molecular modelling of the CRA 
and CA  Hosts (A, B) as well as their complexes  
with pimariic acid (C), abietic acid (D), and 
dehydroabietic acid (E) was performed (Figure 
3). 
 
 
       A                                                B 
  
      C                                                 D                                      
 
 
 
 
                                   E                          
Figure 3. Energy minimized structures 
of CRA (A), CA (B), and complexes CA-
pimaric acid (C), CRA-abietic acid (D), and 
CA-dehydroabietic acid (E). (Hyrogen bonds 
are presented by dotted lines. PhO substituents 
in CRA molecule are omitted for clarity). 
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In the complexes C,D,E the acid Guests 
11,14,15 are included into three-dimentional 
molecular cavities of the Hosts CA and CRA 
decorated with imino or phosphoryl groups 
respectively. The complexes are stabilized by 
the hydrogen bonds of C(O)OH groups of the 
Guests with nitrogen or oxygen atoms of the 
calixarene Hosts. For example, pimaric acid 11 
forms hydrogen bonds with nitrogen atom of 
C=N group at the upper rim of calixarene CA 
(N…O distance 3.11-3.17 Ǻ). At the same time 
dehydroabietic acid 14 forms hydrogen bond 
with oxygen atom of  OH group at the CA 
lower rim. Carboxylic group of abietic acid 15 
in complex D interacts with oxygen atom of 
P=O group at the upper rim of CRA (O…O 
distance 3.45-3.65Ǻ).  
Conclusions 
CA and CRA decorated with protonoaccepting 
imino or phosphoryl groups at the upper rim of 
macrocycle form stable supramolecular Host-
Guest complexes with bio-active aromatic, 
pyridine and diterpenoid carboxylic acids in 
water-organic  solution. The stability constants 
determined by RP HPLC method are depended 
on structure of the Host and Guest molecules 
and vary from 387 M-1  tо 1914 M-1. Molecular 
modelling show that the inclusion complexes  
formed are stabilized by the intermolecular 
hydrogen bonds  of C(O)OH groups of the 
Guests with protonoaccepting nitrogen or 
oxygen atoms at the upper or the lower rim of 
the calixarene Hosts. 
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Experimental part 
Reagents  
CRA was synthesized by the method [32] and 
CA by the method [33]. 
Methods and equipment 
RP HPLC analysis 
RP HPLC analysis was performed on the 
high pressure liquid chromatograph Hitachi 
(Hitachi, Ltd., Tokyo, Japan) in isocratic 
conditions using the column LiChrosorb RP 18 
(Merck, Darmstadt, Germany) as a stationary 
phase. The calixarene based mobile phases were 
prepared by dissolving of the CRA in mixture 
MeОН/H2O/formic acid (75/25/0.01, v/v) or CA 
in mixture MeCN/H2O/formic acid (86/14/0.01, 
v/v). The calixarene concentration in the mobile 
phase vary from 0.1 х 10-4 М to 1.20 х 10-4 М. 
A volume of the sample injected was 20 μL. All 
chromatograms were obtained at 26 °C. UV 
detector was operated at 254 nm and the flow 
rate was 0.8 ml/min.  
Determination of log P of the resin acids 
Values of log P of the resin acids 11-16 were 
calculated from the equation log P = 7.746 . (log 
k'). The coefficient 7.746 is the relation of log P 
value of  abietic acid (6.46) [34] to its log k‘ 
(0.834), determined by RP HPLC in this work. 
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Abietic acid was chosen as a standard 
compound in the calculation of the lipophilicity 
other log P resin acids 11-16. It should be noted 
log P values of the acids determined by RP 
HPLC method are slightly different for mobile 
phases MeОН/H2O/formic acid (75/25/0.01, 
v/v) (CRA) and MeCN/H2O/formic acid 
(86/14/0.01, v/v) (CA).  
Моlecular modelling 
The molecular modelling of CA and 
CRA and their complexes with the acids was 
carried out by molecular mechanics ММ+ 
method, force field PM3 (software package 
Hyper Chem, version 8) [35]. RMS gradient 
was 0.01 kcal/mol.  
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